RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Allergan Inc.

A collection of news and information related to Allergan Inc. published by this site and its partners.

Top Allergan Inc. Articles

Displaying items 23-33
  • U.S. senators seek review of proposed Valeant buyout of Allergan

    Seven U.S. senators have asked the Justice Department and Federal Trade Commission to review the proposed acquisition of Botox maker Allergan Inc. by a Canadian company, saying the deal could increase consumer pricing and curtail the development of new...
  • Allergan employees, Irvine officials worried over Valeant offer

    Allergan employees, Irvine officials worried over Valeant offer
    Wall Street sharks are not the only ones keeping a close watch on the contentious battle for control of Allergan Inc., the Irvine company that makes Botox. So are thousands of the company's scientists and researchers, many of whose jobs may be at risk....
  • Breakfast with a champion: Montgomerie

    Breakfast with a champion: Montgomerie
    The 20th Toshiba Classic won't disappoint when it comes to its annual Breakfast With a Champion, as World Golf Hall of Fame member Colin Montgomerie, a 41-time professional winner who joined the Champions Tour in 2013, will be the keynote speaker on March...
  • Allergan board rejects latest Valeant offer

    The board of Botox maker Allergan Inc. unanimously rejected an increased buyout offer from a Canadian pharmaceutical company as the closely watched acquisition effort showed no signs of a resolution. Valeant Pharmaceuticals International Inc. last month...
  • Allergan questions viability, experience of would-be buyer Valeant

    A day before would-be buyer Valeant Pharmaceuticals is set to unveil a second, unsolicited takeover bid, its acquisition target, Allergan Inc., sought to discredit the company by filing a presentation with regulators questioning the viability of Valeant's...
  • Allergan steps up attack on Valeant

    The billion-dollar takeover battle targeting Irvine-based Allergan is heading into high gear this week with both sides on the attack. On Tuesday, Allergan Inc., the maker of Botox, launched a broadside against Canadian rival Valeant Pharmaceutics...
  • New Valeant bid for Botox maker Allergan 'disappointing,' analyst says

    New Valeant bid for Botox maker Allergan 'disappointing,' analyst says
    Valeant on Wednesday boosted its cash-stock offer to buy Irvine company and Botox maker Allergan to $58.30 a share, raising the cash portion by $10, in a deal now worth about $50 billion.  The Canadian company offered its second, improved bid in the...
  • Valeant hikes its takeover offer for Allergan

    For weeks, Valeant Pharmaceuticals had promised a better offer for Botox maker Allergan, but its renewed cash-and-stock offer fell flat with investors and analysts. After Irvine-based Allergan Inc. rejected a $46-billion offer earlier this month, the...
  • Valeant again raises bid for Allergan

    Valeant again raises bid for Allergan
    For the second time in a week, Canadian drug maker Valeant Pharmaceuticals has raised its offer to acquire Botox maker Allergan Inc.  The revised offer issued Friday now lifts the proposed deal value to about $53 billion, up from Wednesday's bid of...
  • Valeant raises offer for Allergan for 2nd time this week

    For the second time in a week, Canadian drug maker Valeant Pharmaceuticals has raised its offer to acquire Botox maker Allergan Inc. The revised offer issued Friday lifts the proposed deal's value to about $53 billion, up from Wednesday's bid of about...
  • Ackman turns up heat on Allergan, calls for shareholder meeting

    The jockeying for control of Botox maker Allergan Inc. is getting nastier. Activist investor Bill Ackman called Monday for a special meeting at which Allergan shareholders could potentially vote out the bulk of the Irvine company's board of directors....